Evidence map›Paper›PMID 31938148›Full record

ArticleInternational journal of clinical and experimental pathology2018

MicroRNA-10a inhibits A30P α-synuclein aggregation and toxicity by targeting proapoptotic protein BCL2L11.

Huimin Liang, Bingqian Ding, Junhui Liang, Xiaoyan Shi, Xin Jiang, Yang Gao

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in International journal of clinical and experimental pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson's Disease.International journal of molecular sciences · 2020
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Huimin LiangDepartment of Neurology, Huaihe Hospital of Henan University Kaifeng, Henan, P. R. China.
Bingqian DingDepartment of Neurology, Huaihe Hospital of Henan University Kaifeng, Henan, P. R. China.
Junhui LiangDepartment of Laboratory Medicine, Wugang People's Hospital Pingdingshan, Henan, P. R. China.
Xiaoyan ShiCollege of Pharmacy, Henan University Kaifeng, Henan, P. R. China.
Xin JiangDepartment of Neurology, Huaihe Hospital of Henan University Kaifeng, Henan, P. R. China.
Yang GaoDepartment of Neurology, Huaihe Hospital of Henan University Kaifeng, Henan, P. R. China.
Henan University Huaihe Hospital and Huaihe Clinical Institute · CNHenan University · CNPingdingshan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disorder around the world, and is characterized by progressive loss of nigrostriatal dopaminergic neurons. Certain microRNAs (miRNAs) are aberrantly expressed in the post-mortem brain tissues of patients with PD and

Indexed as

B-cell lymphoma like 11microRNA-10aParkinson’s diseasetoxicityα-synuclein

Identifiers

PMID31938148
PMCPMC6958036
OpenAlexW3013050030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.